PMID: 6245319Feb 18, 1980Paper

Opioid peptides

Life Sciences
M W Adler

Abstract

No abstract listed.

References

Aug 1, 1976·Proceedings of the National Academy of Sciences of the United States of America·H H LohC H Li
May 26, 1978·Science·J D BarchasS J Watson
Nov 1, 1976·Proceedings of the National Academy of Sciences of the United States of America·L F TsengC H Li
Dec 1, 1976·Life Sciences·B Pomeranz, D Chiu
Jun 9, 1977·Nature·J A LordH W Kosterlitz
Feb 1, 1978·Proceedings of the National Academy of Sciences of the United States of America·M RubinsteinS Udenfriend
Jan 1, 1977·Proceedings of the National Academy of Sciences of the United States of America·A DupontC H Li
Jun 1, 1977·Proceedings of the National Academy of Sciences of the United States of America·R A NicollR Guillemin
Oct 1, 1978·Proceedings of the National Academy of Sciences of the United States of America·S J HenriksenR Guillemin
Nov 1, 1977·Proceedings of the National Academy of Sciences of the United States of America·S J WatsonC H Li
Mar 1, 1978·Proceedings of the National Academy of Sciences of the United States of America·F E BloomR Guillemin
Sep 29, 1977·Nature·K JhamandasM Sutak
Jun 3, 1976·Nature·H H BuscherJ Pless
Apr 15, 1976·Nature·A A WaterfieldH W Kosterlitz
Apr 1, 1976·Proceedings of the National Academy of Sciences of the United States of America·C H Li, D Chung
Jun 1, 1976·Proceedings of the National Academy of Sciences of the United States of America·B M CoxC H Hi
Jun 1, 1976·Proceedings of the National Academy of Sciences of the United States of America·A R GintzlerS Spector
Jun 15, 1975·Life Sciences·G W PasternakS H Snyder
May 1, 1975·Acta Physiologica Scandinavica·L Terenius, A Wahlström
Apr 15, 1976·Nature·C H Li, D Chung
Jul 1, 1973·Proceedings of the National Academy of Sciences of the United States of America·E J SimonI Edelman
Mar 9, 1973·Science·C B Pert, S H Snyder
Dec 24, 1971·Science·D J MayerJ C Liebeskind
Aug 1, 1971·Proceedings of the National Academy of Sciences of the United States of America·A GoldsteinB K Pal

Citations

Jan 1, 1984·Journal of Neural Transmission·J J Askenasy, M D Yahr
Aug 8, 1983·Life Sciences·R B MurrayA D Korczyn
Dec 1, 1982·Pharmacology, Biochemistry, and Behavior·P R OeltgenR D Myers
Dec 1, 1992·Pharmacology, Biochemistry, and Behavior·C P Dokla
May 1, 1982·Peptides·T L O'Donohue, D M Dorsa
Jan 1, 1983·General Pharmacology·M T Curtis, A M Lefer
Jan 1, 1982·Progress in Neuro-psychopharmacology & Biological Psychiatry·S Szara
Feb 1, 1996·Critical Care Medicine·R BellamyH Zar
Jan 27, 1997·Transplantation·S F BollingP R Oeltgen
Apr 26, 2002·Menopause : the Journal of the North American Menopause Society·Susan R Davis
May 1, 1985·Alcoholism, Clinical and Experimental Research·R R WatsonC Eskelson
Jul 1, 1982·Medicinal Research Reviews·M S GoldM P Dackis
Oct 1, 1981·International Journal of Peptide and Protein Research·D J Phelps, J R Godin
Oct 1, 1984·Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie·J N Nestoros
Dec 6, 2007·Expert Review of Neurotherapeutics·Jeanne Leventhal AlexanderGregg Richardson
Dec 1, 2006·Human Reproduction Update·Andrea Riccardo GenazzaniMichele Luisi
Jun 1, 1984·The Australian and New Zealand Journal of Psychiatry·A P Blaszczynski, S W Winter
Jul 25, 1998·The European Journal of Contraception & Reproductive Health Care : the Official Journal of the European Society of Contraception·M StomatiA R Genazzani
May 24, 2005·CNS Spectrums·Andrea Riccardo GenazzaniMichele Luisi
May 1, 1985·Progress in Cardiovascular Diseases·M W JohnsonC S Wilcox
Feb 1, 1981·Metabolism: Clinical and Experimental·J E Morley

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Hereditary Sensory Autonomic Neuropathy

Hereditary Sensory Autonomic Neuropathies are a group of inherited neurodegenerative disorders characterized clinically by loss of sensation and autonomic dysfunction. Here is the latest research on these neuropathies.

Glut1 Deficiency

Glut1 deficiency, an autosomal dominant, genetic metabolic disorder associated with a deficiency of GLUT1, the protein that transports glucose across the blood brain barrier, is characterized by mental and motor developmental delays and infantile seizures. Follow the latest research on Glut1 deficiency with this feed.

Regulation of Vocal-Motor Plasticity

Dopaminergic projections to the basal ganglia and nucleus accumbens shape the learning and plasticity of motivated behaviors across species including the regulation of vocal-motor plasticity and performance in songbirds. Discover the latest research on the regulation of vocal-motor plasticity here.

Neural Activity: Imaging

Imaging of neural activity in vivo has developed rapidly recently with the advancement of fluorescence microscopy, including new applications using miniaturized microscopes (miniscopes). This feed follows the progress in this growing field.

Nodding Syndrome

Nodding Syndrome is a neurological and epileptiform disorder characterized by psychomotor, mental, and growth retardation. Discover the latest research on Nodding Syndrome here.

LRRK2 & Microtubules

Mutations in the LRRK2 gene are risk-factors for developing Parkinson’s disease (PD). LRRK2 mutations in PD have been shown to enhance its association with microtubules. Here is the latest research.